Shandong University: Helicobacter Infections trials
The registry lists 12 Helicobacter Infections studies with Shandong University as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 4 8No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled TrialNot yet recruitingNCT07720037Phase 4
- The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori InfectionStatus unknownNCT05620589
- The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical TrialStatus unknownNCT05586113Phase 4
- 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori InfectionStatus unknownNCT05438550Phase 4
- Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori InfectionStatus unknownNCT05133193Not applicable
- Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori InfectionStatus unknownNCT04991584Not applicable
- Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong ProvinceCompletedNCT04918134
- Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori InfectionStatus unknownNCT03726099Phase 4
- Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori InfectionCompletedNCT03658746Phase 4
- A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03658733Phase 4
- Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03616405Phase 4
- Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.Status unknownNCT03571230Phase 4